Macrocyclic kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9133224
APP PUB NO 20130261086A1
SERIAL NO

13990045

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of Formula (I): wherein variables are defined herein, and pharmaceutically acceptable salts, synthesis, intermediates, formulations, and methods of disease treatment therewith, including cancers for which FAK inhibition is beneficial.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSI PHARMACEUTICALS LLC1 BIOSCIENCE PARK DRIVE FARMINGDALE NY 11735

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crew, Andrew P N. Babylon, US 86 2039
Dong, Hanqing Syosset, US 96 2320
Ferraro, Caterina Fresh Meadows, US 11 574
Sherman, Dan New York, US 11 91
Siu, Kam W Farmingdale, US 9 148

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 15, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00